SLC1A5, SLC3A2, and SLC7A5 are upregulated in various cancer types,[38, 39, 40, 41, 52, 53, 54] which underpins the increased demand for bulk protein synthesis owing to the enhanced proliferation of cancer cells. The gene discussed is SLC3A2; the disease is cancer.